Gilde closes fourth fund on €250m hard-cap

The GP held the first and final close after the launch in October 2015. Loyens was the legal council, and there was no placement agent involved. Domiciled in the Netherlands, the fund has a lifespan of 10 years and aims to make around three transactions per year.

Gilde said its strategy has changed somewhat with the new vehicle, because the digital health sector has become more important.

The new fund is considerably larger than its predecessor, Gilde Healthcare III, which closed on €145m in November 2013. 

Investments
Gilde Healthcare IV targets opportunities in medtech, digital health and therapeutics, with a geographical focus on Europe and North America.

The fund will invest between €15-25m in each portfolio company.

Gilde expects to make the first investment via its new vehicle during the second half of 2016.

Investors
Royal Philips, an LP in Gilde Healthcare III, acted as a cornerstone investor in Gilde IV, while Johnson & Johnson Innovation joined as a new corporate investor.

Additional backers include funds-of-funds, sovereign wealth funds such as Danish growth fund Vækstfonden, endowments, family offices, entrepreneurs and Gilde's management team. The European Investment Fund participated through the European Recovery Program and Dutch Venture Initiative II.

People
Gilde Healthcare – Pieter van der Meer (managing partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• Benelux
• Netherlands
• Venture